摘要
应用来曲唑治疗3个月的男性部分性特发性低促性腺激素性性腺功能减退症(idiopathic hypogonadotropic hypogonadism,IHH)患者18例。治疗3个月后LH[(3.6±3.7对2.1±1.5) IU/L,P=0.029]和FSH[(4.3±3.4对2.6±1.8) IU/L,P=0.003]均较治疗前明显升高。总睾酮从治疗前(87±42) ng/dl升高至(166±200) ng/dl(P=0.082)。雌二醇从(22.7±18.7) pg/ml降至(13.4±10.6) pg/ml(P=0.020)。治疗前后睾丸体积(两侧睾丸体积平均值)分别是(11.2±4.9)和(14.3±3.9) ml(P<0.01)。在完善精液常规的9例患者中,有8例治疗后精液中可检测到精子。线性模型分析的结果显示,促性腺激素释放激素类似物(曲普瑞林)兴奋试验中LH(60 min)水平较高者,药物治疗后总睾酮水平更容易升高( P=0.045)。
[Summary] Eighteen patients with idiopathic hypogonadotropic hypogonadism( IHH) receiving aromatase-inhibitor( AI) letrozole for at least 3 months were recruited.After 3 months′treatment, LH levels were increased from (2.1 ±1.5) IU/L to (3.6 ±3.7) IU/L(P=0.029), and FSH levels from (2.6±1.8) IU/L to (4.3 ±3.4) IU/L (P=0.003).Total testosterol was increased from (87 ±42) ng/dl to (166 ±200) ng/dl(P=0.082), and estradiol wasdecreasedfrom(22.7±18.7) pg/ml to (13.4±10.6) pg/ml(P=0.020).The average testis volume was increased[(14.3 ±3.9 vs 11.2 ±4.9) ml, P<0.01].Sperms were detected in 8 out of 9 patients who did seminal fluid test.The result of general linear model showed that LH(60 min) was significantly related with total testosterol increment( P=0.045) .
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2016年第2期125-127,共3页
Chinese Journal of Endocrinology and Metabolism